Physician profile
Stacy Townsend
NPI 1275029928
$1,703.82
in general payments reported to CMS, 2019-2025
26 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,019 · 2022: $685.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $301.97 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $241.54 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $148.85 | 2021-2022 | |
| Lilly USA, LLC | $112.86 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $104.87 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $101.02 | 2021 | |
| Amarin Pharma, INC. | $81.21 | 2021-2022 | |
| Biogen, INC. | $79.02 | 2021-2022 | |
| Abbvie INC. | $74.11 | 2021-2022 | |
| Kowa Pharmaceuticals America, INC. | $63.00 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $53.15 | 2022 | |
| Sanofi-Aventis U.S. LLC | $53.06 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $46.10 | 2021-2022 | |
| Abbott Laboratories | $41.96 | 2022 | |
| Novartis Pharmaceuticals Corporation | $30.72 | 2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $20.61 | 2021 | |
| Esperion Therapeutics, INC. | $17.65 | 2021 | |
| Mylan Specialty L.P. | $17.57 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.54 | 2022 | |
| Eisai INC. | $16.10 | 2021 | |
| Astellas Pharma US INC | $15.34 | 2021 | |
| Pfizer INC. | $14.31 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.17 | 2022 | |
| Daiichi Sankyo INC. | $13.52 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $12.84 | 2022 | |
| Dexcom, INC. | $11.73 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacy Townsend listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.